InMed Pharmaceuticals a publicly traded Canadian canna biopharmaceutical company CEO Eric Adams speak with Dan Humiston about their company's Biosynthesis research and their development of three canna drugs in their pipeline.

Produced by PodCONX

https://podconx.com/guests/eric-adams

Produced by PodConx

MJBulls - https://podconx.com/podcasts/raising-cannabis-capital

Dan Humiston - https://www.linkedin.com/in/humiston/

Sound Design - Jamie Humiston - https://www.linkedin.com/in/jamie-humiston-91718b1b3/

Recorded on Squadcast - https://squadcast.fm/